Pfizer Updates 2015 Financial Guidance Solely To Include Hospira Operations In Financial Results From September 3, 2015 Through Year-End 2015
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced updates to certain components of its 2015 financial guidance(1) solely to reflect the impact of the recently completed acquisition of Hospira, Inc. (Hospira).
On September 3, 2015, Pfizer completed the acquisition of Hospira. Pfizer's fiscal year-end for international subsidiaries is November 30, 2015, and Pfizer's fiscal year-end for U.S. subsidiaries is December 31, 2015. Consequently, Pfizer's 2015 financial results will include approximately three months of legacy Hospira international operations and approximately four months of legacy Hospira U.S. operations.
Help employers find you! Check out all the jobs and post your resume.
On September 3, 2015, Pfizer completed the acquisition of Hospira. Pfizer's fiscal year-end for international subsidiaries is November 30, 2015, and Pfizer's fiscal year-end for U.S. subsidiaries is December 31, 2015. Consequently, Pfizer's 2015 financial results will include approximately three months of legacy Hospira international operations and approximately four months of legacy Hospira U.S. operations.
Help employers find you! Check out all the jobs and post your resume.